NYSE: ARX
Accelerant Holdings Stock Forecast, Predictions & Price Target

Analyst price target for ARX

Based on 7 analysts offering 12 month price targets for Accelerant Holdings

Min Forecast
$23.00+14.54%
Avg Forecast
$30.29+50.83%
Max Forecast
$35.00+74.3%

Should I buy or sell ARX stock?

Based on 7 analysts offering ratings for Accelerant Holdings.

Buy
Strong Buy
1 analysts 14.29%
Buy
3 analysts 42.86%
Hold
3 analysts 42.86%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ARX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ARX stock forecasts and price targets.

ARX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-29
lockedlocked$00.00+00.00%2025-08-29
lockedlocked$00.00+00.00%2025-08-18
lockedlocked$00.00+00.00%2025-08-18
lockedlocked$00.00+00.00%2025-08-18
Morgan Stanley
Bottom 13%
13
HoldInitiates Coverage On$28.00+39.44%2025-08-18
BMO Capital
Top 19%
82
BuyInitiates Coverage On$34.00+69.32%2025-08-18

1 of 1

Forecast return on equity

Is ARX forecast to generate an efficient return?

Company
50.62%
Industry
33.43%
Market
-19.25%
ARX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARX forecast to generate an efficient return on assets?

Company
2.34%
Industry
7.57%
ARX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARX earnings per share forecast

What is ARX's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.58
Avg 2 year Forecast
$0.65
Avg 3 year Forecast
$0.80

ARX revenue forecast

What is ARX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$905.9M
Avg 2 year Forecast
$1.0B
Avg 3 year Forecast
$1.2B

ARX vs Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
ARX$20.08$30.29+50.83%Buy
CRVL$87.56N/AN/A
BWIN$31.35$42.60+35.89%Hold
TWFG$24.89$34.40+38.21%Buy
CRD.A$10.39$14.00+34.74%Buy

Accelerant Holdings Stock Forecast FAQ

Is Accelerant Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: ARX) stock is to Buy ARX stock.

Out of 7 analysts, 1 (14.29%) are recommending ARX as a Strong Buy, 3 (42.86%) are recommending ARX as a Buy, 3 (42.86%) are recommending ARX as a Hold, 0 (0%) are recommending ARX as a Sell, and 0 (0%) are recommending ARX as a Strong Sell.

If you're new to stock investing, here's how to buy Accelerant Holdings stock.

What is ARX's earnings growth forecast for 2025-2027?

(NYSE: ARX) Accelerant Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Insurance Brokers industry's average forecast earnings growth rate of 48.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.67%.

Accelerant Holdings's earnings in 2025 is N/A.On average, 5 Wall Street analysts forecast ARX's earnings for 2025 to be $128,472,153, with the lowest ARX earnings forecast at $98,993,953, and the highest ARX earnings forecast at $158,390,325. On average, 5 Wall Street analysts forecast ARX's earnings for 2026 to be $142,991,266, with the lowest ARX earnings forecast at $131,991,938, and the highest ARX earnings forecast at $158,390,325.

In 2027, ARX is forecast to generate $175,263,295 in earnings, with the lowest earnings forecast at $173,789,385 and the highest earnings forecast at $175,989,250.

What is ARX's revenue growth forecast for 2025-2027?

(NYSE: ARX) Accelerant Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Insurance Brokers industry's average forecast revenue growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.88%.

Accelerant Holdings's revenue in 2025 is N/A.On average, 4 Wall Street analysts forecast ARX's revenue for 2025 to be $199,292,866,992, with the lowest ARX revenue forecast at $193,060,207,689, and the highest ARX revenue forecast at $203,707,557,338. On average, 4 Wall Street analysts forecast ARX's revenue for 2026 to be $227,720,630,595, with the lowest ARX revenue forecast at $217,632,706,776, and the highest ARX revenue forecast at $236,705,541,788.

In 2027, ARX is forecast to generate $260,349,257,606 in revenue, with the lowest revenue forecast at $258,799,892,243 and the highest revenue forecast at $262,003,996,533.

What is ARX's forecast return on assets (ROA) for 2025-2027?

(NYSE: ARX) forecast ROA is 2.34%, which is lower than the forecast US Insurance Brokers industry average of 7.57%.

What is ARX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ARX price target, the average ARX price target is $30.29, with the highest ARX stock price forecast at $35.00 and the lowest ARX stock price forecast at $23.00.

On average, Wall Street analysts predict that Accelerant Holdings's share price could reach $30.29 by Aug 29, 2026. The average Accelerant Holdings stock price prediction forecasts a potential upside of 50.83% from the current ARX share price of $20.08.

What is ARX's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: ARX) Accelerant Holdings's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that ARX's EPS will be $0.58 for 2025, with the lowest EPS forecast at $0.45, and the highest EPS forecast at $0.72. On average, analysts forecast that ARX's EPS will be $0.65 for 2026, with the lowest EPS forecast at $0.60, and the highest EPS forecast at $0.72. In 2027, ARX's EPS is forecast to hit $0.80 (min: $0.79, max: $0.80).

What is ARX's forecast return on equity (ROE) for 2025-2027?

(NYSE: ARX) forecast ROE is 50.62%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.